Cargando…
Exploring the impact of dexamethasone on gene regulation in myeloma cells
Among glucocorticoids (GCs), dexamethasone (Dex) is widely used in treatment of multiple myelomas. However, despite a definite benefit, all patients relapse. Moreover, the molecular basis of glucocorticoid efficacy remains elusive. To determine genomic response to Dex in myeloma cells, we generated...
Autores principales: | Bessonneau-Gaborit, Victor, Cruard, Jonathan, Guerin-Charbonnel, Catherine, Derrien, Jennifer, Alberge, Jean-Baptiste, Douillard, Elise, Devic, Magali, Deshayes, Sophie, Campion, Loïc, Westermann, Frank, Moreau, Phillipe, Herrmann, Carl, Bourdon, Jérémie, Magrangeas, Florence, Minvielle, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390781/ https://www.ncbi.nlm.nih.gov/pubmed/37524526 http://dx.doi.org/10.26508/lsa.202302195 |
Ejemplares similares
-
The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability
por: Derrien, Jennifer, et al.
Publicado: (2021) -
S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA
por: Derrien, Jennifer, et al.
Publicado: (2023) -
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma
por: Alberge, Jean-Baptiste, et al.
Publicado: (2020) -
Logic programming reveals alteration of key transcription factors in multiple myeloma
por: Miannay, Bertrand, et al.
Publicado: (2017) -
Constraints on signaling network logic reveal functional subgraphs on Multiple Myeloma OMIC data
por: Miannay, Bertrand, et al.
Publicado: (2018)